Holen Sie sich die Stockscreener-App
0.7501
7.68%
-0.0624
Handel nachbörslich:
.75
-0.000100
-0.01%
Schlusskurs vom Vortag:
$0.8125
Offen:
$0.795
24-Stunden-Volumen:
127.86K
Relative Volume:
0.09
Marktkapitalisierung:
$2.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.08M
KGV:
-0.3394
EPS:
-2.21
Netto-Cashflow:
$-11.54M
1W Leistung:
-16.56%
1M Leistung:
-31.18%
6M Leistung:
-64.95%
1J Leistung:
-92.92%
1-Tages-Spanne:
$0.61
$0.80
1-Wochen-Bereich:
$0.61
$0.97
52-Wochen-Spanne:
$0.61
$12.37
Bio Path Holdings Inc Stock (BPTH) Company Profile
Firmenname
Bio Path Holdings Inc
Sektor
Branche
Telefon
(832) 742-1357
Adresse
4710 BELLAIRE BOULEVARD, BELLAIRE, TX
Vergleichen Sie BPTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| BPTH | 0.7501 | 2.89M | 0 | -16.08M | -11.54M | -2.21 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-11 | Eingeleitet | ROTH Capital | Buy |
| 2017-11-13 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-04-18 | Eingeleitet | Rodman & Renshaw | Buy |
| 2014-06-02 | Fortgesetzt | Maxim Group | Buy |
| 2014-05-09 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Bio Path Holdings Inc Aktie (BPTH) Neueste Nachrichten
Biotricity, Inc. (NASDAQ:BTCY) Q2 2025 Earnings Call Transcript - Insider Monkey
BIO-key International Reports Financial Results for Third Quarter 2024 - Defense World
First National Corporation (NASDAQ:FXNC) Declares Quarterly Cash Dividend of $0.155 per Share - Defense World
Arbutus Biopharma Announces Positive Data from Clinical Trials at AASLD – The Liver Meeting® 2024 - Defense World
Empire Petroleum Corporation Report Q3 2024 Financial and Operating Results - Defense World
Bio-Path Holdings Reports Third Quarter 2024 Financial Results and Expansion into Obesity Program - Defense World
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2024 Earnings Call Transcript - Insider Monkey
Bio-Path: Q3 Earnings Snapshot - New Haven Register
Bio-Path Holdings Expands DNAbilize® Technology Applications - TipRanks
Earnings call: Bio-Path Holdings reports Q3 2024 financials, pipeline updates - Investing.com Nigeria
Bio-Path Holdings Reports Third Quarter 2024 Financial Results - citybiz
Bio-Path Holdings Expands to Obesity Market, Reports $2.1M Q3 Loss, Raises $4M | BPTH Stock News - StockTitan
Bio-Path Holdings Inc (BPTH) Quarterly 10-Q Report - Quartzy
Some Numbers at Parker Drilling that Make Your Stock Look Good - AOL
Bio Path Holdings Inc expected to post a loss of $1.02 a shareEarnings Preview - XM
Bio-Path (BPTH) Scheduled to Post Quarterly Earnings on Friday - Defense World
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024 - StockTitan
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma - The Manila Times
Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at StockNews.com - Defense World
BPTH stock touches 52-week low at $0.84 amid sharp annual decline - Investing.com UK
T-cell Malignancies Clinical Trial Pipeline Insights Featuring 70+ Companies | DelveInsight - The Malaysian Reserve
Antisense Oligonucleotide Therapeutics Market Poised for Significant Growth, Projected to Reach $64.64 Bill... - WhaTech
RNA Interference Therapy Competitive Landscape Report 2024 (Updated) - openPR
Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com - Defense World
RNA-based Therapeutics Market Latest Trends Analysis Report 2024 - InsightAce Analytic
siRNA Therapeutics Market Set for Explosive Growth, Projected to Reach $48.46 Billion by 2031 - WhaTech
80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港
siRNA Therapeutics Market Set for Explosive Growth, Expected to Hit $48.46 Billion by 2031 As Revealed In N... - WhaTech
Thyroid Cancer Drug Market to Exhibit a Remarkable CAGR of 17.2% - openPR
Chronic Myeloid Leukemia (CML) Treatment Market Report Analysis, Research Studies |Novartis AG, Bristol-Myers Squibb, Te – IndiaPolitics.com - IndiaPolitics.com
Antisense Oligonucleotide (ASO) Therapeutics Market Size, Share, and Future Growth Analysis (2024-2032) - News in Assen
Antisense and RNAi Therapeutics Market Growth, Share, and Industry Forecast (2024-2032) - News in Assen
Wells Fargo & Company (WFC-N) QuotePress Release - The Globe and Mail
New World Solutions (CSE: NEWS) (OTC: REGRF) Appoints Capital Markets Veteran Martin Tremblay to Board of Directors - Wall Street Reporter
Analytical Overview: Bio-Path Holdings Inc (BPTH)’s Ratios Tell a Financial Story - The Dwinnex
Bio-Path Holdings Raises $4M Through Private Placement - TipRanks
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
Why this investor is skeptical about Tesla's robotaxi event - Yahoo Finance UK
Portfolio manager sees 'no landing' for US economy - Yahoo Finance UK
Russia to raise foreign company 'exit tax' to 35% from 15%, business daily reports - Yahoo Finance UK
Delta eyes Election Day travel pullback as profits climb - Yahoo Finance UK
Orient Green Power Shares Surge 7%, Outperform Sector Despite 'Strong Sell' Rating - Yahoo Finance UK
Prepare Yourself for Liftoff: Bio-Path Holdings Inc (BPTH) - SETE News
Dubai's DP World to use Hong Kong supply chain provider to connect China with the world - Yahoo Finance UK
Hungary central banker flags likely pause in rate cuts after forint falls - Yahoo Finance UK
Antisense Oligonucleotides Market Latest Sales Figure Signals More Opportunities Ahead - Elektrotransports.lv
Brookfield wins round Tritax Eurobox in £1.1bn tie-up - Yahoo Finance UK
London landlord GPE benefits from better investment conditions - Yahoo Finance UK
Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ... - Yahoo Finance
Bio-Path Holdings Inc [BPTH] Revenue clocked in at $0.00 million, down -87.15% YTD: What’s Next? - The DBT News
Finanzdaten der Bio Path Holdings Inc-Aktie (BPTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):